DSIP Peptide Therapy
Understanding DSIP
An overview of delta sleep-inducing peptide (DSIP), a research peptide studied in laboratory and academic settings.
Important Information
DSIP is not FDA-approved and is not offered at Cienega Medical. This page is for general education only and is not medical advice.
What Is DSIP?
DSIP (delta sleep-inducing peptide) is a small peptide composed of nine amino acids that was first isolated in 1977 from the brains of laboratory animals. It is classified as a research peptide and is the subject of academic and preclinical scientific literature. DSIP is not an approved drug. The U.S. Food and Drug Administration (FDA) has not approved DSIP for any medical use, and it has not been evaluated by the FDA for safety or effectiveness. It is not available as a prescription medication or as an over-the-counter product in the United States.
FAQ
Click on a question to see more
-
What is DSIP?
DSIP, or delta sleep-inducing peptide, is a peptide made up of nine amino acids that was first identified in the 1970s during laboratory research. It is a compound discussed in academic and preclinical scientific literature and is generally classified as a research peptide.
-
Is DSIP FDA-approved?
No. DSIP is not approved by the U.S. Food and Drug Administration for any use. It has not been evaluated by the FDA for safety or effectiveness and is not sold as an approved prescription or over-the-counter product in the United States.
-
Does Cienega Medical offer DSIP?
No. DSIP is not offered at Cienega Medical. This page exists only as general educational information about the peptide.
Cared for by our 15-person Los Angeles medical team. Meet your provider →